Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | tumor protein p53 | Starlite/ChEMBL | No references |
Homo sapiens | glycoprotein hormones, alpha polypeptide | Starlite/ChEMBL | No references |
Rattus norvegicus | Inositol monophosphatase 1 | Starlite/ChEMBL | No references |
Homo sapiens | glutaminase | Starlite/ChEMBL | No references |
Homo sapiens | euchromatic histone-lysine N-methyltransferase 2 | Starlite/ChEMBL | No references |
Homo sapiens | ataxin 2 | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | inositol-1 | 0.0045 | 0.0375 | 0.0473 |
Echinococcus granulosus | Mitotic checkpoint protein PRCC C terminal | 0.0133 | 0.2715 | 0.2631 |
Schistosoma mansoni | hypothetical protein | 0.0133 | 0.2715 | 0.3296 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.0776 | 0.0977 |
Schistosoma mansoni | tar DNA-binding protein | 0.0067 | 0.0965 | 0.1051 |
Brugia malayi | Pre-SET motif family protein | 0.0036 | 0.0149 | 0.0187 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0067 | 0.0965 | 0.1216 |
Brugia malayi | Pre-SET motif family protein | 0.0251 | 0.585 | 0.7371 |
Brugia malayi | RNA binding protein | 0.0067 | 0.0965 | 0.1216 |
Loa Loa (eye worm) | glutaminase 2 | 0.033 | 0.7936 | 1 |
Echinococcus granulosus | tar DNA binding protein | 0.0067 | 0.0965 | 0.0862 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0036 | 0.0149 | 0.0002 |
Mycobacterium ulcerans | glutaminase | 0.033 | 0.7936 | 1 |
Schistosoma mansoni | thyroid hormone receptor | 0.0144 | 0.2997 | 0.3659 |
Loa Loa (eye worm) | hypothetical protein | 0.0036 | 0.0149 | 0.0187 |
Mycobacterium leprae | possible inositol monophosphatase SubH (IMPase) (inositol-1-phosphatase) (I-1-Pase ). | 0.004 | 0.0251 | 0.5 |
Brugia malayi | Inositol-1 | 0.0045 | 0.0375 | 0.0473 |
Brugia malayi | glutaminase DH11.1 | 0.033 | 0.7936 | 1 |
Trypanosoma brucei | inositol-1(or 4)-monophosphatase 1, putative | 0.0045 | 0.0375 | 1 |
Loa Loa (eye worm) | TAR-binding protein | 0.0067 | 0.0965 | 0.1216 |
Echinococcus multilocularis | Mitotic checkpoint protein PRCC, C terminal | 0.0133 | 0.2715 | 0.2605 |
Schistosoma mansoni | thyroid hormone receptor | 0.0144 | 0.2997 | 0.3659 |
Plasmodium vivax | SET domain protein, putative | 0.0036 | 0.0149 | 1 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0036 | 0.0149 | 0.0002 |
Leishmania major | myo-inositol-1(or 4)-monophosphatase 1, putative | 0.0045 | 0.0375 | 1 |
Loa Loa (eye worm) | glutaminase | 0.033 | 0.7936 | 1 |
Onchocerca volvulus | 0.0286 | 0.6769 | 1 | |
Schistosoma mansoni | cellular tumor antigen P53 | 0.006 | 0.0776 | 0.0807 |
Schistosoma mansoni | inositol monophosphatase | 0.0045 | 0.0375 | 0.0293 |
Echinococcus multilocularis | thyroid hormone receptor alpha | 0.0144 | 0.2997 | 0.2892 |
Trichomonas vaginalis | glutaminase, putative | 0.033 | 0.7936 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0067 | 0.0965 | 0.1051 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0053 | 0.0588 | 0.0741 |
Loa Loa (eye worm) | RNA binding protein | 0.0067 | 0.0965 | 0.1216 |
Echinococcus multilocularis | tar DNA binding protein | 0.0067 | 0.0965 | 0.0829 |
Loa Loa (eye worm) | hypothetical protein | 0.0036 | 0.0147 | 0.0185 |
Mycobacterium tuberculosis | Inositol-1-monophosphatase SuhB | 0.004 | 0.0251 | 0.5 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0036 | 0.0149 | 0.0002 |
Echinococcus granulosus | inositol monophosphatase 1 | 0.0045 | 0.0375 | 0.0265 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0067 | 0.0965 | 0.1216 |
Brugia malayi | TAR-binding protein | 0.0067 | 0.0965 | 0.1216 |
Trichomonas vaginalis | set domain proteins, putative | 0.0286 | 0.6769 | 0.8457 |
Entamoeba histolytica | myo-inositol monophosphatase, putative | 0.0045 | 0.0375 | 0.5 |
Echinococcus granulosus | histone lysine methyltransferase setb | 0.0036 | 0.0149 | 0.0036 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.003 | 0 | 0.5 |
Echinococcus multilocularis | inositol monophosphatase 1 | 0.0045 | 0.0375 | 0.023 |
Schistosoma mansoni | tar DNA-binding protein | 0.0067 | 0.0965 | 0.1051 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.003 | 0 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | fructose-1,6-bisphosphatase | 0.0045 | 0.0375 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0053 | 0.0588 | 0.0741 |
Schistosoma mansoni | inositol monophosphatase | 0.0045 | 0.0375 | 0.0293 |
Schistosoma mansoni | glutaminase | 0.033 | 0.7936 | 1 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0251 | 0.585 | 0.7371 |
Toxoplasma gondii | inositol(myo)-1(or 4)-monophosphatase 2, putative | 0.0045 | 0.0375 | 1 |
Trypanosoma cruzi | myo-inositol-1(or 4)-monophosphatase 1, putative | 0.0045 | 0.0375 | 1 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0053 | 0.0588 | 0.0741 |
Echinococcus multilocularis | tumor protein p63 | 0.0408 | 1 | 1 |
Schistosoma mansoni | histone-lysine n-methyltransferase suv9 | 0.0036 | 0.0149 | 0.0002 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0053 | 0.0588 | 0.0741 |
Toxoplasma gondii | histone lysine methyltransferase SET/SUV39 | 0.0036 | 0.0149 | 0.396 |
Schistosoma mansoni | tar DNA-binding protein | 0.0067 | 0.0965 | 0.1051 |
Trypanosoma cruzi | myo-inositol-1(or 4)-monophosphatase 1, putative | 0.0045 | 0.0375 | 1 |
Onchocerca volvulus | 0.006 | 0.0776 | 0.0947 | |
Schistosoma mansoni | tar DNA-binding protein | 0.0067 | 0.0965 | 0.1051 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0036 | 0.0147 | 0.0185 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.1122 uM | PubChem BioAssay. qHTS for Inhibitors of Glutaminase (GLS). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 1.7783 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | 3.9811 uM | PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 6.3096 um | PUBCHEM_BIOASSAY: qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 7.3753 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 10 uM | PUBCHEM_BIOASSAY: qHTS assay for re-activators of p53 using a Luc reporter. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504709] | ChEMBL. | No reference |
Potency (functional) | 12.5893 uM | PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 18.526 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.